Molecular Diagnostics Market Outlook and Forecast up to 2025

transparencymarketresearch_logo

The global molecular diagnostics market is highly consolidated in nature, observes Transparency Market Research. The leading players accounted for a share of 54% in the overall market in 2015. F. Hoffman-La Roche Ltd., Abbott Laboratories, and Danaher Corporation have dominated the global market in the past few years. The broad product portfolio and strategic mergers and acquisitions have been the winning strategies of these players to remain dominant.

According to the research report, the global molecular diagnostic market is estimated to reach a valuation of US$18.9 bn by the end of 2025 as compared to US$7.1 bn in 2016. Between the forecast years of 2016 and 2025, the global market is estimated to expand at a steady CAGR of 11.6%.

Well-established Healthcare Infrastructure in North America Bodes Well for Regional Market

On the basis of technology, the global molecular diagnostics market is segmented into PCR and real-time PCR, hybridization, microarray, transcription-mediated amplification, next-generation sequencing, and others such as mass spectrometry. Of these, the PCR and real-time PCR technology segment is anticipated to show a significant progress during the forecast years. This segment is projected to expand at a CAGR of 11.1% between 2016 and 2025. The extensive usage of this technology is expected to play significant role in its growth.

On the basis of geography, the global molecular diagnostics market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America. Of these, North America is estimated to account for a share of 39.6% in the overall market by the end of 2025. This segment is likely to thrive due to the changing demographics, high prevalence of cancer, evolving lifestyles, and well-established healthcare infrastructure.

Investments in Research and Development Ensure Uptake of Molecular Diagnostic Kits

The global molecular diagnostic market is anticipated to be driven by the growing investments in research and development of biomarkers. The increasing uptake of biomarkers for diagnosis and prognosis as well as prediction and assessment of ongoing has augmented the demand for molecular diagnostics. Several kits designed for molecular diagnostics allow safe, quick, and accurate detection of infectious diseases such as HIV and hepatitis. Thus, the growing interest of big companies in expanding their business through developing biomarker solutions is expected to benefit the overall market.

The continuous evolution in the field of molecular biology has changed the way diseases are being diagnosed and treated. The new methods have the ability to detect bacteria, viruses, and genetic variations in less time in with absolute precision. Thus, the upgrades in technology, which have significantly customized health care have boosted the demand for molecular diagnostics in recent years. Analysts also predict that the wide range of technologies for diagnosis of diseases will give the global market a shot in the arm during the forecast period.

Poor Awareness and Low FDA Approvals to Restrain Market Growth

The long lead time for FDA approvals for molecular diagnostics is severely restraining the growth of the global market. Molecular diagnostics haven’t had a clinical impact on medical practice as was predicted earlier as delays in approvals have created potential hurdles. The market is also being hampered due to the poor reimbursement policies. The low awareness and lack of clarity pertaining to the diagnostic techniques used for detecting various injections and chronic conditions is a key challenge to the growth of the overall market.

This review is based on Transparency Market Research, titled “Molecular Diagnostics Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017-2025.”

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Hemophilia Treatment Drugs Market will explore robust size & growth during 2016-2024

transparencymarketresearch_logo

The global hemophilia drug treatment market features an exceedingly consolidated vendor landscape, with the top three companies, namely Novo Nordisk A/S, Shire Plc., and Pfizer Inc., collectively accounting for a nearly 49% of the market in 2015, observes Transparency Market Research in a recent report. Focus on research and development activities aimed at the discovery of new drug candidates and strategic mergers and acquisitions with the view of expanding geographical reach and enhancing product portfolios are amongst the key strategies adopted by companies to beat competition.

Transparency Market Research estimates that the market will exhibit a promising 5.4% CAGR over the period between 2016 and 2024, rising from a valuation of US$15.8 bn in 2015 to US$25.1 bn by 2024.

North America to Retain Position as Dominant Market for Hemophilia Treatment Drugs

Of the key hemophilia treatment drug varieties available in the global market, including desmopressin, plasma derived coagulation factor concentrates, recombinant coagulation factor concentrates, and antifibrinolytic agents, the segment of recombinant coagulation factor concentrates presently dominates. Their dominance is chiefly attributable to their low risk of causing blood-related infections. The segment is also poised to lead through the forecast period, acquiring nearly 47% of the overall market by 2024.

From a geographical perspective, the hemophilia treatment drugs market is presently the most lucrative and significant market for hemophilia treatment drugs, mostly owing to the high disposable incomes of patients and a well-established healthcare infrastructure. The region is likely to remain the leading contributor of revenue and business to the global hemophilia treatment drugs market on account of the presence of leading vendors and a rising population of hemophilia patients. The region is expected to acquire a nearly 41% of the global market by 2024.

Development of Novel Drugs Varieties to Drive Market

The rising prevalence of hemophilia is the primary driver of the global hemophilia treatment drugs market. Technological advancements in hemophilia drug innovation, along with the development of novel coagulating factors promising long-lasting clotting, are anticipated to contribute towards the growth of the market in the near future. An instance of one of the novel long-lasting clotting agents being developed is the drug emicizumab by Roche Pharmaceuticals.

Clinical studies have demonstrated that people treated with emicizumab prophylaxis showed a statistically significant decline in the number of bleeds over a certain period as compared to people who received no prophylactic treatment. The demand for this type of treatment is expected to rise with time with rising consumer awareness about its benefits.

High Costs Restrain Sale of Drugs in Developing and Lesser-developed Economies

The high cost of hemophilia drugs is one of the key challenges hindering the overall development of the hemophilia treatment drugs market, especially across developing and lesser-developed economies. The market also faces the challenge of low diagnosis rate. Despite availability of generic testing for hemophilia, lack of awareness among patients restricts the potential patient base of the market, especially in remote parts of the world.

This review of the market is based on a recent market research report published by Transparency Market Research, titled “Hemophilia Treatment Drugs Market (Product – Recombinant Coagulation Factor Concentrates, Plasma Derived Coagulation Factor Concentrates, Desmopressin, and Antifibrinolytic Agents; Disease Indication – Hemophilia A, Hemophilia B, Acquired Hemophilia, and Hemophilia C; Distribution Channel – Hospital Pharmacies, Retail Pharmacies, and E-commerce) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”

Contact us:

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY – 12207

United States

Tel: +1-518-618-1030

USA – Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

 

Medical Waste Management Market 2017-2022 Top 15 Players Analysis Research Report

Medical Waste Management market

Latest niche market research report on “Global Medical Waste Management Detailed Analysis Report 2017-2022” published to orbisresearch.com’s store.

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Medical Waste Management industry.

This report splits Medical Waste Management market By Technology, By Waste Type, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report focuses Global market, it covers details as following:
Major Companies
Stericycle (US)
Sharps Compliance (US)
Veolia Environment (US)
Daniels Sharpsmart (US)
Clean Harbors (US)
MedWaste Management (US)
ATI (US)
Republic Services (US)
Waste Management (US)
Medical Waste Services (US)
Excel Medical Waste (US)
Cyntox (US)
Triumvirate (US)
BioMedical Waste Solutions (US)
UMI (US)

Main Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Main Product Type
Medical Waste Management Market, by Technology
Incineration
Autoclaves
Microwave

Medical Waste Management Market, by Waste Type
Infectious Waste
Hazardous Waste
Radioactive Waste
General Waste

Main Applications
Hospitals
Clinics
Other

Major points from Table of Contents:
Chapter One: Medical Waste Management Market Overview
Chapter Two: Medical Waste Management by Regions 2012-2017
Chapter Three: Medical Waste Management by Players 2012-2017
Chapter Four: Medical Waste Management by Consumer 2012-2017
Chapter Five: Global Top Players Profile
Chapter Six: Industry Chain and Supply Chain
Chapter Seven: Global Medical Waste Management Market Size (Sales and Revenue) Forecast (2017-2022)
Chapter Eight: Development Trend and Research Conclusion
Chapter Nine: Methodology and Data Source

Contact enquiry@orbisresearch.com for more information.

MHealth Market by Product, Application, and Service – Global Industry Analysis and Forecast to 2025

MHealth Market Overview:

The outlook towards healthcare has drastically changed in recent times. The use of mobile and wireless technology has enabled the transformation of health services delivery across the globe; the most crucial contribution being the elimination of the geographic distance or boundaries between the patients and the healthcare providers. The proliferation of mobile devices and electronic health systems is creating wonders in the healthcare industry. With the advent of mobile technology based products and services, diagnosis and treatment decisions are becoming more patient centric. These products provide key information and early warnings about an illness. mHealth is a medical practice enabled and supported by different mobile devices such as mobile phones, tablets, computers, patient monitoring devices, personal digital assistants, and other wireless devices. Lately, mHealth has become a necessity rather than an option. mHealth applications are being widely used by doctors in their daily practice. They assist doctors to consult, diagnose, treat, and monitor their patients. Doctors can provide optimal treatment to their patients as mHealth enables them to lookup patient’s information instantly and take informed decisions.

Rapid increase in penetration of smartphones, rising utilization of mHealth mobile apps by people, high adoption of wireless technology enabled medical devices by the healthcare industry, and increased emphasis on patient-centric healthcare service delivery are some of factors contributing to the market growth. According to the data revealed by the National Center for Biotechnology Information (NCBI), as of 2015, two-third of the overall U.S. population and 82% of U.S. citizens in the age group 18 to 49 years owned an app enabled mobile-phone. With rising penetration of high speed internet connectivity in low and middle income countries and availability of affordable smartphones, the global mHealth market is set to witness robust growth in next five years. However, concerns related to data security and resistance by traditional healthcare providers in developing countries can hamper the growth of the global mHealth market.

Rapid innovations will characterize the future growth of the mHealth market. With more and more companies launching innovative products, the competition in the market is and will be fierce over the coming years. Emerging markets propose lucrative growth opportunities for mHealth providers. For instance, in January 2016, the Government of India launched Kilkari, a mobile health service under the Digital India program. This platform delivers weekly audio messages to the expecting mothers giving them helpful insights about child care, pregnancy, and child birth.

The major players have been developing highly sophisticated products to outperform their competitors in the global mHealth market. In June 2014, Apple, Inc. launched Healthkit, a health data tracking platform which collects data from different fitness and health apps and makes it available to Apple users through its Health app. Likewise, in March 2016, Apple, Inc. launched Carekit, a software framework which enables users to keep a track of care plans, and monitor symptoms and medication. Carekit also enables users to share information with family members, nurses, and doctors.   Moreover, in September 2016, Nike Inc. and Apple Inc. collaborated together to launch the Apple Watch Nike+, a combination of Apple Watch Series 2 and Nike sports bands along with integration with the Nike+ Run Club app. This device is exclusively designed for runners to assist them in scheduling, monitoring, and enhancing their running routines.

Some of the key players competing in the mHealth market are Medtronic plc., Mobisante, Inc., Sanofi, AirStrip Technologies, LifeWatch Services, Inc., AliveCor, Inc., Koninklijke Philips N.V., Nike Inc., Johnson & Johnson, OMRON Corporation, Jawbone, AgaMatrix, Inc., BioTelemetry, Inc., iHealth Labs Inc., AT&T Inc., Cerner Corporation, Cisco, Inc. and Qualcomm Technologies, Inc.

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:

Judy

304 South Jones Blvd, Suite 1896,

Las Vegas NV 89107,

United States

Toll Free: +1-888-213-4282

Email: sales@crystalmarketresearch.com

Silver Wound Dressings Market by Type and Treatment – Global Industry Analysis and Forecast to 2025

Silver Wound Dressings Market Overview:

Skin is an organ which protects the body from the external factors such as bacteria and viruses. Lacerations, surgical wounds, cuts and burns are skin injuries. Laceration is a wound that is produced by tearing of tissue or skin. Laceration can be short or long, wide or narrow and deep or shallow. The cause of laceration is object hitting the skin. Surgical wound is a cut made by a cutting instrument during  surgery. Surgical wounds are of different sizes and they are made in sterile environment. They are either closed or left open to heal. The signs and symptoms of surgical wounds are fever, redness, swelling and increased pain at infected area. There are four classes of surgical wounds, namely, class I, class II, class III, and class IV. Class I wounds are clean wounds which show no indications of inflammation or infection. They involve vascular system or skin. Class II wounds are clean contaminated wounds. They involve respiratory and gastrointestinal wounds. Class III wounds are contaminated wound and arise due to outside objects coming in contact with the wound. Class IV wounds are dirty contaminated wounds. They involve wounds exposed to fecal matter. Cut is another skin injury, which is a closed or an open wound on the skin. Cuts can be caused by sharp objects tearing the skin tissue. Burns are injuries to the skin caused by sunlight, radiation, or any form of heat. Symptoms of burns are large blisters, redness, and swelling.

Dressing is an important part in managing wounds. Silver is used in these dressings due its broad-spectrum antimicrobial property. Silver dressings are made of hydrofibre or foam. Silver wound dressings are used in cuts, surgical wounds, burns and lacerations. The silver wound dressing decreases the bioburden in chronic or acute wounds. Silver found in dressings is in the form of an organic complex, elemental silver or as an inorganic compound. Silver cannot kill bacteria in its unreactive metallic form and ionization of silver is necessary. The external surface of the dressing is coated with silver or it is mixed in the composite before molding. A continuous film is formed on the dressing matrix due to silver ions solution. Silver shows its antimicrobial action when it comes in contact with the wound. Silver affects at various sites and interferes with the cell metabolism. Silver destroys the bacterial cell wall and lead to bacterial cell death.

The major factor responsible for the growth of silver wound dressings market is the increase in prevalence of diabetes. According to IDF, in 2015, diabetes affected 415 million people worldwide. This number is expected to reach up to 642 million by 2040. Further, the rise in the geriatric population will fuel the growth of this market. According to WHO, in 2015, 900 million people were 60 years of age or older and this number is expected to reach up to 2 billion by 2050. Moreover, increase in the incidence of ulcers will further boost the growth of this market. However, the high cost of development and lack of efficacy of silver wound dressing can hamper the growth of silver wound dressings market.

The key strategy followed by major players in the silver wound dressings market is product extension to gain more market share. For instance, in September 2016, ConvaTec Group launched AQUACEL Ag Surgical SP dressing in U.S. It is an extension of AQUACEL Ag Surgical cover dressings which helps to minimize the infections at surgical site. By the launch of AQUACEL Ag Surgical SP dressing, ConvaTec Group will gain more market share.

The major market players in the silver wound dressings market are B. Braun Melsungen AG, Smith & Nephew PLC, 3M, Acelity LP, Inc., Medline industries, and ConvaTec Group.

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:

Judy

304 South Jones Blvd, Suite 1896,

Las Vegas NV 89107,

United States

Toll Free: +1-888-213-4282

Email: sales@crystalmarketresearch.com

Medical Imaging Equipment Market by Product – Global Industry Analysis and Forecast to 2025

Medical Imaging Equipment Market Overview:

Over the past few decades, medical imaging has greatly revolutionized the healthcare industry. Medical imaging allows doctors to diagnose diseases at an early stage and drastically improve patient outcomes. Today, advanced medical imaging technologies deliver substantial benefits to the healthcare providers and the patients as well. Medical imaging assists physicians in better understanding the complications in the human body. The procedures are completely non-invasive, painless and majority of these procedures don’t require any special prior preparation. With the introduction of surgical C-arm machines for imaging, complicated surgeries have become highly feasible over the years. Such devices are used in orthopedic, cardiology, and traumatology for intra-operative imaging purposes.

Medical imaging modalities can be classified into conventional X-ray examinations, computed tomography (CT), nuclear medicine imaging, ultrasound imaging and magnetic resonance imaging (MRI). The basic principle used in X-ray imaging is very much similar to ordinary photography. In normal photography, visible low energy light is used whereas in X-ray imaging high energy, invisible light is used. The extent of X-ray penetration in the human body depends upon the materials in the human body such as, bones, soft tissues, and air/gas. CT imaging is a rapid imaging process which combines the power of X-rays and advanced computers to generate cross sectional, 360 degree views. In nuclear imaging, unsealed radioactivity is used in order to create functional images. Ultrasound refers to sound waves with frequencies higher than 20,000 HZ which cannot be recognized by human ear. For most of the diagnostic purposes, the frequency range is maintained between 3.5 and 7 MHz. Different examination probes attached to the ultrasound equipment have different frequencies which can be used for imaging different organs and tissue structures. MRI imaging has crucial applications in examination of the central nervous system including the spinal cord as well as in examination of anatomical abnormalities such as congenital heart malformations.

Some of the key factors driving the growth of medical imaging equipment market are the growing prevalence of target diseases (such as cardiac disorders and cancers) coupled with increased patient awareness about early diagnosis of diseases, rising incidence of accident related severe injuries, and technological advancements in medical imaging techniques. However, factors such as high costs of medical imaging equipment along with the risk of side effects associated with emitted radiations can hamper the growth of medical imaging equipment market.

The major players operating in the global medical imaging equipment market emphasize on product development facilitated by technological innovations along with strategic collaborations in order to gain competitive advantage in the market. For instance, in September 2016, GE Healthcare in collaboration with Trice Imaging, Inc. launched a cloud based solution, Tricefy. Tricefy allows clinicians to share medical imaging results with patients and remote colleagues.

Some of the key players operating in this market are, Hologic, Inc., Hitachi, Ltd., GE Healthcare, Samsung Medison Co., Ltd., Siemens Healthcare GmbH, Koninklijke Philips N.V., Toshiba Medical Systems Corporation, Shimadzu Corporation, and Carestream Health, Inc.

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:

Judy

304 South Jones Blvd, Suite 1896,

Las Vegas NV 89107,

United States

Toll Free: +1-888-213-4282

Email: sales@crystalmarketresearch.com

Cone Beam Computed Tomography Market Size Is Projected To Be Around $1 Billion By 2025

A research study titled, “Cone Beam Computed Tomography Market by Application – Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the cone beam computed tomography market is projected to be around $1 billion by 2025.

Cone beam computed tomography (CBCT) is imaging technique used for clinical assessment of dental patients. It is special type of x-ray machines used fordental and facial x-rays. CBCT uses special type of technology to generate 3D images of dental structures and facial bones. 3D images obtained helps dentist to plan precise treatment accordingly. Dental problems are one of the most common issues faced by large number of people worldwide. Dental problems are any issues related to teeth or gums that can affect oral health of an individual. Periodontal diseases, mouth sores, and tooth erosion are some of the common dental problems faced by large number of individuals. High prevalence of dental problems worldwide can be attributed to number of factors such as unhealthy diet, and high consumption of alcohol and tobacco. Hence, rising number of incidences of dental disorders will demand more advance technologies to detect and treat these disorders and related conditions.

Dental implants segment dominated the global cone beam tomography market in 2016. This can be attributed to a wide range of applications of CBCT in dental imaging procedures for generating 3D images of alveolar bone and adjacent structure, to determine relative location of teeth and assessment of endodontic pathology for designing dental implants and post-procedure monitoring. Oral surgery is second leading application segment, owing to CBCT ability to visualize patient’s anatomy before carrying surgery which allows planning the treatment precisely. Orthodontics segment is poised to witness high growth during forecast period, due to technological advancements in oral imaging and maxillofacial.

North America accounted for the largest share of the global market in 2016, followed by Europe. According to study published by the United Nations Department of Economic and Social Affairs in 2015, geriatric population is expected to reach around 2.1 billion by 2050. Such a high prevalence of elderly population will be a key factor contributing to the CBCT market. Asia-Pacific is poised to grow at highest CAGR over the forecast period, due to high patient population, rise in elderly population, and increase awareness about oral health with growing disposable income of people.

Major players in the market are Sirona Dental Systems, Cefla Group, Carestream Health, QR s.r.l., VATECH Global Co. Ltd., Danaher Corporation, Planmeca OY, and Prexion, Inc.

Key Findings of the Research Study:

  • Dental implants segment dominated the global market in 2016, due to increased utilization of CBCT in designing dental implants and post procedure monitoring.
  • Orthodontics segment is poised to witness high growth during the forecast period due to technological advancements in maxillofacial and oral imaging.
  • S. accounted for the largest share of North America market in 2016, due to rise in geriatric population and high adoption rate of highly advanced medical devices.
  • Asia-Pacific region is expected to witness high growth during the forecast period, owing to large number of people suffering from dental disorders and increasing geriatric population.
  • Emerging economies such as India and China will offer profitable opportunities for the overall growth of the market owing to large population base requiring dental treatments.

Cone Beam Computed Tomography Market is Segmentation as follows

By Application:

  • Orthodontics
  • Oral Surgery
  • Endodontic
  • Dental Implants
  • General Dental Surgery

By Region:

  • North America
  • S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:

Judy

304 South Jones Blvd, Suite 1896,

Las Vegas NV 89107,

United States

Toll Free: +1-888-213-4282

Email: sales@crystalmarketresearch.com

Pen Needle Market Size Is Projected To Be Around $4.9 Billion By 2025

A research study titled, “Pen Needle Market by Type, Needle Length, Therapy and Mode of Purchase – Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the pen needle market is projected to be around $4.9 billion by 2025.

Diabetes is one of the most occurring chronic diseases characterized by either incapability of pancreas to produce glucose or incapability of body to absorb glucose produced by pancreas. According to survey conducted by International Diabetic Federation (IDF) in 2015, around 415 million are living with diabetes with proportion of type-2 diabetics increasing globally. Largenumber of people aged 40 to 59 suffer from diabetes and related complications. Diabetic people have high risk of developing several complications (such as vascular disorders, kidney malfunctioning besides affecting eyes, nerves and teeth) due to high glucose level. Diabetes has long term impact on health and economic condition of individual. Over a period of time, diabetes affect kidney, damages heart vessels, and eyes, leading to malfunctioning of body. Besides, people with diabetes are likely to incur huge expenditure causing financial burdens on them and family members. There are many methods to inject insulin in body such as through syringes and pen needles. Withseveral risks (such as sharp injuries or rapture of blood vessels) associated with the use of syringes; the demand for insulin syringes is expected to decline in near future. However, this will provide ample growth opportunities for the pen needle market.

Standard pen needles segment dominated the global market in 2016, due to growing awareness among consumers about the availability of safe insulin delivery methods, increasing prevalence of diabetes with rise in geriatric population, and standard pen needles being cost effective as compared to other insulin delivery methods. However, standard pen needles are expected to witness decline in the growth during forecast period due to various risks of needle related injuries such as rupture of blood vessel while injecting insulin in the body. Among various needles available, 8mm needle length accounted for the largest share of the global market in 2016; as these needles are prescribe to large number of people including obese people. Insulin therapy segment dominated the overall market in 2016, primarily due to increasing adoption of self-administration of insulin for diabetes type-1 as well as type-2. With increasing trend in e-commerce, online purchase segment will witness high growth during the forecast period.

Europe accounted for the major share of the global pen needles market in 2016, primarily due to rising diabetic population, increased funding for diabetic research, high adoption of technologically advanced devices, and rise in demand for safe insulin delivery methods. However, Asia-Pacific is expected to witness high growth in forecast period, due to increasing demand for better healthcare infrastructure and rise in awareness about commercially available treatments for diabetes.

Major players in the market are Becton, Dickinson and Company, Novo Nordisk A/S, Owen Mumford, Ltd., HTL-STREFA S.A., B. Braun Melsungen, Ypsomed Holding AG, Terumo Corporation, and Allison Medical, Inc. These players are highly focused on developing advanced products for the treatment of diabetes. For instance, in 2013, Becton, Dickinson and Company launched BD Ultra-Fine Nano 4mm pen needle with easy flow technology for easier and faster delivery of insulin in the body. Advanced features such as easy flow with 5mm needles and digitalized pen needles will dominate the market in coming years.

Key Findings of the Research Study:

  • Standard pen needles segment accounted for the largest share of the global market in 2016, due to increase in diabetic population and availability of cost effective standard pen needles.
  • Reusable and disposable pen needles segment accounted for almost equal share with reusable having slightly higher market share in 2016.
  • S. dominated the global market and will continue to dominate during forecast period due to high demand for technologically advanced devices and availability of better health infrastructure.
  • 4mm needle length segment is expected to witness highest growth rate during forecast period due to its short length.
  • Insulin therapy segment dominated the global market in 2016, owing to increasedpreferencefor self-administration of insulin.
  • UK and Germany dominated the European market due to EU’s regulatory framework to minimized needle related injuries and to increase in preference of self-administrative methods.

Pen needle market is segmented on following basis:

By Type:

  • Safety Pen Needles
  • Standard Pen Needles

By Needle Length:

  • 12mm
  • 10mm
  • 8mm
  • 6mm
  • 5mm
  • 4mm

By Therapy:

  • Glucagon-like-Peptide-1 (GLP-1)
  • Insulin
  • Growth Hormone

By Mode of Purchase:

  • Retail
  • Non-retail

By Region:

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • Turkey
  • United Arab Emirates
  • Others

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:

Judy

304 South Jones Blvd, Suite 1896,

Las Vegas NV 89107,

United States

Toll Free: +1-888-213-4282

Email: sales@crystalmarketresearch.com

Continuous Glucose Monitoring Devices Market Size Is Projected To Be Around $1.1 Billion By 2025

A research study titled, “Continuous Glucose Monitoring Devices Market by Product and End User – Global Industry Analysis and Forecast to 2025” published by Crystal Market Research, states that the continuous glucose monitoring devices market is projected to be around $1.1 billion by 2025.

Continuous glucose monitoring (CGM) devices are used to monitor glucose level throughout day and night. A sensor is placed under the skin which measures the glucose level in tissue fluid. A transmitter is connected to the sensor which transfers information via wireless radio frequency. This transmitter is connected to monitoring and display device. These devices are used to monitor blood glucose level of diabetic patients. Diabetes is a chronic disease which is classified into type 1 and type 2. Diabetes occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin. The symptoms of diabetes are frequent urination, blurred vision, increased thirst, rapid weight loss, numbness or tingling sensation in hands or feet and increased hunger. Factors which increase the risk of diabetes are ethnicity, family history of diabetes, and physical inactivity. The exact causes of type 1 diabetes are unknown. Type 1 diabetes can be caused due to complex interaction between genes and environmental factors. The strongest risk factors for type 2 diabetes are overweight and obesity. Diabetes can damage the heart, eyes, blood vessels, kidneys, and nerves which may lead to disability and premature death. People with diabetes are likely to incur disastrous personal health expenditure. According to a study conducted by American Diabetes Association, 415 million people worldwide suffered from diabetes and diabetes related complications as of 2015, and this number is expected to reach 642 million by 2040. Over the past three decades, the predominance of diabetes is increasing, but it is growing at a higher rate in low and middle income countries. As per International Diabetes Federation, about80% of the diabetic population resides in low and middle income countries.

Insulin pumps segment will witness a robust growth during the forecast period, while transmitters and receivers segment occupied a major share of the CGM devices market in 2016.Sensors are disposable components of the CGM systems which need to be replaced every 57 days. Homecare diagnostics segment dominated the global market in 2016, due to high convenience offered byCGM devices in homecare settings for regular monitoring of blood glucose.

North America held a major share of the overall market in 2015. This is attributed to factors such as high predominance of diabetes, growing geriatric population, and improving reimbursement policies. U.S. dominated the North American market owing to the presence of advanced healthcare infrastructure and high disposable income of Americans. Asia-Pacific will bring in significant growth opportunities over the forecast period as the awareness about patient monitoring systems is on the rise along with increased healthcare expenditure.

Technological advancements are set to drive the competitive CGM devices market during the forecast period. Key players are highly focused on developing innovative products to sustain the market competition. For instance, in September 2015, Medtronic launched the MiniMed connect system enabling smartphone connectivity for CGM. In September 2016, Abbott received FDA approval for Freestyle Libre Pro GGM System designed to provide clear visual snapshots of patients’ glucose levels. In January 2017, Dexcom launched Dexcom CLARITY Diabetes Management Solution in EMEA. This software simplifies CGM data reporting and management.

 

Major players in the CGM devices market are Dexcom, Inc., Johnson and Johnson, Insulet Corporation, Medtronic, Abbott Laboratories, Echo Therapeutics, Inc., Tandem Diabetes Care, Inc., Nemaura Medical Inc., F. Hoffmann-La Roche AG, Senseonics Holdings, Inc., and GlySens Incorporated.

Key Findings of the Research Study:

  • Transmitters and receivers segment held the largest share of the global CGM devices market in 2016.
  • Insulin pumps segment will grow with the highest CAGR over the forecast period; these are highly recommended over multiple daily injections for most patients suffering from type 1 diabetes.
  • North America held a major share of the global market in 2016, due to the presence of large patient base and increasing demand for advanced patient monitoring systems.
  • Asia-Pacific is expected to grow at the highest CAGR throughout the forecast period. This is attributed to factors such as the increasing prevalence of diabetes, sedentary lifestyle, and increasing patient awareness about benefits of CGM devices with rise in disposable income of people.

Continuous Glucose Monitoring Devices Market Segmentation

By Product:

  • Insulin Pumps
  • Transmitters and Receivers
  • Sensors

By End User:

  • Homecare Diagnostics
  • Hospitals
  • Others

By Region:

  • North America
    • U.S
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • Rest of the World
    • Brazil
    • South Africa
    • Saudi Arabia
    • Turkey
    • United Arab Emirates
    • Others

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact:

Judy

304 South Jones Blvd, Suite 1896,

Las Vegas NV 89107,

United States

Toll Free: +1-888-213-4282

Email: sales@crystalmarketresearch.com

Global Surgical Robotic Market Trends, Demand, Manufacturers and Opportunities 2017 – Da Vinci Surgical system, Renaissance, Flex

Global Surgical Robots Market

Global Surgical Robots Market is expected to reach USD 14.5 billion by 2024, at a CAGR 13.7% during the forecast period of 2017 to 2024. The report contains 242 pages of exclusive premium insights with 122 tables and 41 figures.

Robotic Surgery is the surgery which is performed by the surgeons with the help of the robotic technology. Robotically assisted surgery was developed to overcome the weaknesses of the traditional methods of surgery, also known as or computer assisted surgery or robot assisted surgery.

The global surgical robots market have been segmented On the basis of product type into systems, instruments and accessories and service.

Based on brands the market is segmented into Da Vinci Surgical system, Renaissance, Flex, Cyberknife, Artas, Rosa and others.

On the basis of application the market have been segmented into general surgery, urological, gynecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, Colon and rectal surgery and others.

Based on end-user the market is segmented into hospitals, clinics, home care settings, research laboratories and, pharma & biotech companies.

Based on geography the global surgical robots market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others.

Major Players Operating in this market:

Intuitive Surgical, Inc., Verb Surgical Inc., Auris Surgical Robots, MedRobots Corporation, Restoration Robots, Inc., Virtual Incision Corporation, Think Surgical, Inc., Medtech Global, TransEnterix, Titan Medical Inc, Stryker, Accuray Inc., MAZOR Robots, Hansen Medical, Capsa Healthcare, LLC, Aesynt Inc, iRobot Corporation, ReWalk Robots, and Hocoma AG among others.

Regions Covered In The Scope Of The Report:

Global (North America (U.S., Canada, Mexico), Europe (Germany, France, U.K., Italy, Spain, Russia, Belgium, Netherlands, Switzerland, Turkey, Rest of Europe), Asia-Pacific (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of APAC), South America (Brazil, Rest of South America), Middle East and Africa (South Africa, Rest of MEA))

About Bharat Book Bureau:
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry study, country reports, business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

Contact us at:
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Email:poonam@bharatbook.com